Wells Fargo’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-296,179
| Closed | -$5.76M | – | 6814 |
|
|
2018
Q1 | $5.76M | Buy |
296,179
+26,930
| +10% | +$529K | ﹤0.01% | 2514 |
|
|
2017
Q4 | $4.48M | Buy |
269,249
+191,184
| +245% | +$3.5M | ﹤0.01% | 2674 |
|
|
2017
Q3 | $1.58M | Buy |
78,065
+16,334
| +26% | +$312K | ﹤0.01% | 3483 |
|
|
2017
Q2 | $994K | Buy |
61,731
+6,338
| +11% | +$93.6K | ﹤0.01% | 3737 |
|
|
2017
Q1 | $701K | Sell |
55,393
-5,965
| -10% | -$72K | ﹤0.01% | 4021 |
|
|
2016
Q4 | $814K | Sell |
61,358
-23,097
| -27% | -$395K | ﹤0.01% | 3851 |
|
|
2016
Q3 | $2M | Buy |
84,455
+46,336
| +122% | +$1.25M | ﹤0.01% | 2964 |
|
|
2016
Q2 | $1.1M | Sell |
38,119
-21,524
| -36% | -$702K | ﹤0.01% | 3423 |
|
|
2016
Q1 | $1.91M | Buy |
59,643
+19,528
| +49% | +$687K | ﹤0.01% | 2959 |
|
|
2015
Q4 | $1.72M | Buy |
40,115
+1,896
| +5% | +$75.7K | ﹤0.01% | 3086 |
|
|
2015
Q3 | $1.34M | Sell |
38,219
-20,450
| -35% | -$921K | ﹤0.01% | 3291 |
|
|
2015
Q2 | $2.69M | Buy |
58,669
+41,192
| +236% | +$1.96M | ﹤0.01% | 2871 |
|
|
2015
Q1 | $819K | Sell |
17,477
-10,356
| -37% | -$412K | ﹤0.01% | 3654 |
|
|
2014
Q4 | $882K | Sell |
27,833
-1,237
| -4% | -$36.2K | ﹤0.01% | 3599 |
|
|
2014
Q3 | $689K | Sell |
29,070
-7,822
| -21% | -$200K | ﹤0.01% | 3694 |
|
|
2014
Q2 | $1.11M | Sell |
36,892
-104,599
| -74% | -$2.82M | ﹤0.01% | 3448 |
|
|
2014
Q1 | $3.73M | Sell |
141,491
-6,796
| -5% | -$170K | ﹤0.01% | 2531 |
|
|
2013
Q4 | $3.73M | Buy |
148,287
+1,616
| +1% | +$36K | ﹤0.01% | 2474 |
|
|
2013
Q3 | $3M | Buy |
146,671
+131,734
| +882% | +$2.72M | ﹤0.01% | 2587 |
|
|
2013
Q2 | $297K | Buy |
+14,937
| New | +$265K | ﹤0.01% | 3940 |
|
Wells Fargo's IPXL Position: Q2 2018 in Review
Wells Fargo sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 296,179 shares — an estimated $5.76M sold.
Wells Fargo first reported a position in IPXL in Q2 2013 and held it in 20 quarters. The position peaked at $5.76M in Q1 2018. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.
- Wells Fargo reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
- Wells Fargo sold 296,179 Impax Laboratories, Inc. shares in Q2 2018, an estimated $5.76M.
- Wells Fargo first reported a position in Impax Laboratories, Inc. in Q2 2013 and held it in 20 quarters.
- Wells Fargo's Impax Laboratories, Inc. position peaked at $5.76M in Q1 2018.
- 1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.
Based on Wells Fargo's 13F filing for Q2 2018, filed 1 Aug 2018.